Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Blood|March 8, 2007
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B studySusan P Whitman, Amy S Ruppert, Guido Marcucci, et al.Blood Advances|May 5, 2021
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myelomaStephan R Bohl, Laura K Schmalbrock, Imke Bauhuf, et al.Blood|October 18, 2007
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplicationsSusan P Whitman, Amy S Ruppert, Michael D Radmacher, et al.American Journal of Hematology|May 5, 2018
Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myelomaXavier Leleu, Tamas Masszi, Nizar J Bahlis, et al.European Journal of Haematology|July 16, 2021
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myelomaChristian Straka, Hans Salwender, Stefan Knop, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B studyChristian Langer, Guido Marcucci, Kelsi B Holland, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2008
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B studyPeter Paschka, Guido Marcucci, Amy S Ruppert, et al.European Journal of Cancer (Oxford, England : 1990)|May 18, 2016
Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantationMaximilian Merz, Lina Jansen, Felipe A Castro, et al.European Journal of Haematology|June 25, 2019
Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trialsChristian Straka, Stefan Knop, Martin Vogel, et al.Blood|April 2, 2008
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) studyChristian Langer, Michael D Radmacher, Amy S Ruppert, et al.Pageof 8